Pediatr. praxi. 2023;24(5):336-342 | DOI: 10.36290/ped.2023.084

Unusual increase of invasive pyogenic streptococci in children

prof. MUDr. Vladimír Mihál, CSc.1, 2, Mgr. Pavla Kučová, Ph.D.3, MUC. Veronika Vašířová2, MUC. Marek Teleky2, MUDr. Kamila Michálková4
1 Ústav molekulární a translační medicíny, LF UP Olomouc
2 Dětská klinika, LF UP a FN v Olomouci
3 Mikrobiologický ústav, LF UP a FN v Olomouci
4 Radiologická klinika, LF UP a FN v Olomouci

Streptococcus pyogenes (group A streptococcus, GAS) causes a wide range of diseases in children, especially pharyngitis and scarlet fever. Less commonly, it can cause serious invasive infections, including necrotizing fasciitis, pneumonia, sepsis and streptococcal toxic shock syndrome. GAS infection requiring hospitalization is still associated with significant serious illness and short- and long-term morbidity in younger children. Early recognition of the disease and prompt antibiotic treatment is the most natural prevention of serious GAS complications today. In children under 10 years of age, the rate of infection with invasive GAS (iGAS) is higher than in the years preceding the COVID-19 pandemic, but significantly higher than in the last two years. In the last year, based on reports of an increase in lower respiratory tract infections in children, particularly empyema, systematic data collection of individual cases is underway to better understand iGAS. We present two preschool children with scarlet fever complicated by pleuropneumonia and respiratory failure.

Keywords: Streptococcus pyogenes, child, invasive streptococcal infections, iGAS, pleuropneumonia, respiratory failure.

Accepted: October 9, 2023; Published: October 13, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mihál V, Kučová P, Vašířová V, Teleky M, Michálková K. Unusual increase of invasive pyogenic streptococci in children. Pediatr. praxi. 2023;24(5):336-342. doi: 10.36290/ped.2023.084.
Download citation

References

  1. Carapetis JR, Steer AC, Mulholland EK, et al. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685-694. Go to original source... Go to PubMed...
  2. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000;13(3):470-511. Go to original source... Go to PubMed...
  3. Garancini N, Ricci G, Ghezzi M, et al. Invasive Group A streptococcal infections: are we facing a new outbreak? A case series with the experience of a single tertiary center. Ital J Pediatr. 2023;19;49(1):88-94. Go to original source... Go to PubMed...
  4. Ledford H. Why is strep a surging - and how worried are scientists? Nature. 2022 Dec;612(7941):603. doi: 10.1038/d41586-022-04403-y. PMID: 36494446. Go to original source... Go to PubMed...
  5. Retamoza R, Gregora M, Fleischmannová J, et al. Povstání pyogenních streptokoků. Pediatr. praxi. 2023;24(4):33-36. Go to original source...
  6. Case Definition for Invasive Group A Streptococcal Infection (iGAS). In: www.hpsc.ie [Internet]. 2022 Dec 22. [cited 2023 May 28]. Available from: https://www.hpsc.ie/az/other/groupastreptococcaldiseasegas/casedefinition/.
  7. Beneš J, Rozsypal H. Diskuse k výskytu závažných streptokokových infekcí. In: infektologie.cz [Internet]. 2023 Mar 03. [cited 2023 May 29]. Available from: https://infektologie.cz/ zprava23-06.htm.
  8. Kozáková J. Aktuálně z NRL pro streptokokové nákazy. In: szu.cz [Internet]. 2023 Feb 03. [cited 2023 May 28]. Available from: https://szu.cz/tema/a-z-infekce/s/streptokokova-infekce/aktualne-z-nrl-pro-streptokokove-nakazy/.
  9. Beneš J, Džupová O. Upozornění na výskyt závažných invazivních streptokokových infekcí. In: infektologie.cz [Internet]. 2023 Feb 28. [cited 2023 May 29]. Available from: https:// infektologie.cz/zprava23-05.htm.
  10. Aktuálně z NRL pro streptokokové nákazy [Internet]. [cited 2023 May 29]. Available from: https://szu.cz/tema/a-z- -infekce/s/streptokokova-infekce/aktualne-z-nrl-pro streptokokove-nakazy/.
  11. Heinige P, Prchlík M, Zaoral T, et al. Upozornění pracovní skupiny sekce intenzivní medicíny při České pediatrické společnosti na opakovaný výskyt velmi závažných invazivních infekcí pyogenními streptokoky v ČR. Čes-slov Pediat. 2023;78(5):281-282.
  12. Lamagni TL, Darenberg J, Luca-Harari B, et al. Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol. 2008;46:2359-2367. Go to original source... Go to PubMed...
  13. Tapiainen T, Launonen S, Renko M, et al. Invasive Group A Streptococcal Infections in Children: A Nationwide Survey in Finland. Pediatr Infect Dis J. 2016;35(2):123-128. Go to original source... Go to PubMed...
  14. Avire NJ, Whiley H, Ross K. A Review of Streptococcus pyogenes: Public health risk factors, prevention and control. Pathogens. 2021;22;10(2):248-265. Go to original source... Go to PubMed...
  15. Canetti M, Carmi A, Paret G, et al. Invasive group A streptococcus infection in children in central Israel in 2012-2019. Pediatr Infect Dis J. 2021;1;40(7):612-616. Go to original source... Go to PubMed...
  16. Nagy A, Reyes JA, Chiasson DA. Fatal pediatric streptococcal infection: A clinico-pathological study. Pediatr Dev Pathol. 2022;25(4):409-418. Go to original source... Go to PubMed...
  17. Ibrahim J, Eisen JA, Jospin G, Coil DA, et al. Genome analysis of Streptococcus pyogenes associated with pharyngitis and skin Infections. PLoS One. 2016 Dec 15;11(12):e0168177. doi: 10.1371/journal.pone.0168177. PMID: 27977735; PMCID: PMC5158041. Go to original source... Go to PubMed...
  18. Zimbelman J, Palmer A, Todd J. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis. 1999;18(12):1096-100. Go to original source... Go to PubMed...
  19. Johnson AF, LaRock CN. Antibiotic treatment, mechanisms for failure, and adjunctive therapies for infections by group A streptococcus. Front Microbiol. 2021;4;12:760255. doi: 10.3389/fmicb.2021.760255. PMID: 34803985; PMCID: PMC8601407. Go to original source... Go to PubMed...
  20. Wang S-M, Lu I-H, Lin YL. et al. The severity of Streptococcus pyogenes infections in children is significantly associated with plasma levels of inflammatory cytokines. Diagn Microbiol Infect Dis. 2008;61(2):165-169. Go to original source... Go to PubMed...
  21. Boeddha NP, Atkins L, de Groot R, et al. Group A streptococcal disease in paediatric inpatients: a European perspective. Eur J Pediatr. 2023;182(2):697-706. Go to original source... Go to PubMed...
  22. Hoste L, Van Paemel R, Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review. Eur J Pediatr. 2021;180(7):2019-2034. Go to original source... Go to PubMed...
  23. Abraham P, Marin G, Filleron A, et al. Evaluation of post-infectious inflammatory reactions in a retrospective study of 3 common invasive bacterial infections in pediatrics. Medicine (Baltimore). 2022 Sep 23;101(38):e30506. doi: 10.1097/MD.0000000000030506. PMID: 36197203; PMCID: PMC9509192. Go to original source... Go to PubMed...
  24. Ginsburg I, Ward PA, Varani J. Can we learn from the pathogenetic strategies of group A hemolytic streptococci how tissues are injured and organs fail in post-infectious and inflammatory sequelae? FEMS Immunol Med Microbiol. 1999;25(4):325-338. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.